blank

China’s CanSino defends COVID-19 vaccine candidate

Earlier, scientists said that the success of the company's vaccine might be limited as it is based on a common cold virus that many people have been exposed to. They said existing antibodies against the common cold virus might undermine Ad5-nCoV.